Lido Advisors’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.7K | Hold |
10,000
| – | – | ﹤0.01% | 1435 |
|
|
2025
Q1 | $22K | Hold |
10,000
| – | – | ﹤0.01% | 1348 |
|
|
2024
Q4 | $15.3K | Sell |
10,000
-35,308
| -78% | -$54K | ﹤0.01% | 1315 |
|
|
2024
Q3 | $90.2K | Hold |
45,308
| – | – | ﹤0.01% | 1231 |
|
|
2024
Q2 | $159K | Hold |
45,308
| – | – | ﹤0.01% | 1170 |
|
|
2024
Q1 | $126K | Sell |
45,308
-1,627
| -3% | -$4.51K | ﹤0.01% | 1169 |
|
|
2023
Q4 | $79.8K | Buy |
46,935
+7,500
| +19% | +$12.8K | ﹤0.01% | 1141 |
|
|
2023
Q3 | $40.6K | Buy |
39,435
+2,500
| +7% | +$2.58K | ﹤0.01% | 1006 |
|
|
2023
Q2 | $42.8K | Buy |
36,935
+1,627
| +5% | +$1.89K | ﹤0.01% | 1015 |
|
|
2023
Q1 | $53.3K | Hold |
35,308
| – | – | ﹤0.01% | 963 |
|
|
2022
Q4 | $88.3K | Hold |
35,308
| – | – | ﹤0.01% | 821 |
|
|
2022
Q3 | $148K | Hold |
35,308
| – | – | ﹤0.01% | 792 |
|
|
2022
Q2 | $98K | Hold |
35,308
| – | – | ﹤0.01% | 793 |
|
|
2022
Q1 | $201K | Buy |
35,308
+16,576
| +88% | +$94.4K | ﹤0.01% | 838 |
|
|
2021
Q4 | $171K | Hold |
18,732
| – | – | ﹤0.01% | 852 |
|
|
2021
Q3 | $200K | Hold |
18,732
| – | – | ﹤0.01% | 816 |
|
|
2021
Q2 | $291K | Buy |
+18,732
| New | +$291K | ﹤0.01% | 634 |
|